<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03585868</url>
  </required_header>
  <id_info>
    <org_study_id>COFRE-LIICM</org_study_id>
    <nct_id>NCT03585868</nct_id>
  </id_info>
  <brief_title>Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)</brief_title>
  <acronym>COFRE</acronym>
  <official_title>Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Polytechnic Institute, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Polytechnic Institute, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study use a double blind, placebo-controlled design enrolling male and female subjects&#xD;
      between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on&#xD;
      anthropometric, metabolic, oxidative stress, physical performance and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study use a double blind, placebo-controlled design enrolling male and female subjects&#xD;
      between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids;&#xD;
      F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All&#xD;
      beverages had similar physical characteristics and flavor. Cocoa beverages were provided in&#xD;
      individual sachets containing a dry powder that was reconstituted with water just before&#xD;
      consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit&#xD;
      intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30&#xD;
      min/day.&#xD;
&#xD;
      To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic&#xD;
      parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density&#xD;
      lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative&#xD;
      stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein&#xD;
      carbonylation is measured using an assay for detection of carbonyl groups that relies on&#xD;
      2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate&#xD;
      interleukin-6 and tumor necrosis factor levels.&#xD;
&#xD;
      For physical performance is evaluated the handgrip strength, and mobility assesment with the&#xD;
      following test: Six-minute walk test, two-minute step, sit-up test and the up &amp; go test.&#xD;
&#xD;
      The investigators also assessed quality of life using the Health Related QoL (EQ-5D)&#xD;
      questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triacylglycerol concentration</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum total cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum HDL cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum LDL cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid oxidation</measure>
    <time_frame>At 90 days</time_frame>
    <description>Serum malondialdehyde Levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protein oxidation</measure>
    <time_frame>At 90days</time_frame>
    <description>Serum protein carbonylation Levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>At 60 days</time_frame>
    <description>Measures static force in kilograms that the hand can squeeze around a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Up and go test</measure>
    <time_frame>At 60 days</time_frame>
    <description>Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>6 minutes</time_frame>
    <description>Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two-minute step in place test</measure>
    <time_frame>2 minutes</time_frame>
    <description>Measures number of times a subject can rise each knee to the hip level during 2 minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sit-up test</measure>
    <time_frame>30 seconds</time_frame>
    <description>Measures number of times a subject can rise and sit-down in place during 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D questionnaire</measure>
    <time_frame>At 60 days</time_frame>
    <description>Self-administered health index that explores five domains</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analog Visual Scale</measure>
    <time_frame>At 60 days</time_frame>
    <description>Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Frail Elderly Syndrome</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Beverage without flavonoids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Flavonoids</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Beverage with alkalinized cocoa which eliminates flavonoid content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavonoids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Beverage with a flavonoid rich mixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Beverage with no flavonoids</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flavonoids</intervention_name>
    <description>Flavonoids-enriched cacao beverage</description>
    <arm_group_label>Flavonoids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No Flavonoids</intervention_name>
    <description>Beverage with alkalinized cocoa which eliminates flavonoid content</description>
    <arm_group_label>No Flavonoids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Sex: both&#xD;
&#xD;
          -  Age: 55-90 yo&#xD;
&#xD;
          -  Waist circumference: Women &gt; 80 cm, Men &gt; 90 cm&#xD;
&#xD;
          -  HDL-c: Women &lt; 50 mg/dL, Men &lt; 40 mg/dL&#xD;
&#xD;
          -  Triglycerides: ≥ 150 mg/dL&#xD;
&#xD;
          -  Glycemia: ≈100 mg/dL&#xD;
&#xD;
          -  Hand strength: Women&lt; 20 kg, Men &lt; 30 kg&#xD;
&#xD;
          -  Up &amp; Go test: &gt; 10 seconds&#xD;
&#xD;
        Non-inclusion criteria:&#xD;
&#xD;
          -  Any active infections&#xD;
&#xD;
          -  Malignancies&#xD;
&#xD;
          -  Habitual consumers of antioxidant supplements and cocoa products&#xD;
&#xD;
          -  Use of benzodiazepines or protein supplements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>May 16, 2018</study_first_submitted>
  <study_first_submitted_qc>July 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2018</study_first_posted>
  <last_update_submitted>July 12, 2018</last_update_submitted>
  <last_update_submitted_qc>July 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Polytechnic Institute, Mexico</investigator_affiliation>
    <investigator_full_name>Guillermo Ceballos Reyes</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>flavonoids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

